Zealand Pharma A/S has expanded its management team with the appointment, effective 1 March, of Ivan Møller to the newly created position of head of technical development and operations. In this role he will help the company prepare for further commercial launches. Mr Moller previously worked at Novartis where he managed manufacturing for both generics and branded pharmaceutical products. Prior to Novartis, he was a project leader at The Boston Consulting Group in New York, US.
Mr Moller holds a master of science degree in chemical engineering from the Technical University of Denmark and a master of business administration from Harvard Business School.
Zealand Pharma announced the appointment on 19 January 2018.
Copyright 2018 Evernow Publishing Ltd